Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) — Net Asset Momentum
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) recorded a net asset momentum of 16.8% as of December 2025, with net assets of CN¥1.96 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check how tangible is Shandong Bailong Chuangyuan Bio-Tech Co.'s equity to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Net Asset Momentum (2016–2025)
This chart tracks Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s year-over-year net asset growth across 10 annual reporting periods from 2016 to 2025. The most recent momentum reading is +16.8%, with net assets of CN¥1.96 Billion CNY as of December 2025. Read Shandong Bailong Chuangyuan Bio-Tech Co. balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
The table below shows the complete annual net asset history for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025, covering 10 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 605016 stock market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.96 Billion | CN¥2.44 Billion | CN¥475.19 Million | ▲ +16.8% |
| 2024 | CN¥1.68 Billion | CN¥2.01 Billion | CN¥334.27 Million | ▲ +11.4% |
| 2023 | CN¥1.51 Billion | CN¥1.75 Billion | CN¥246.35 Million | ▲ +12.1% |
| 2022 | CN¥1.34 Billion | CN¥1.47 Billion | CN¥126.99 Million | ▲ +11.8% |
| 2021 | CN¥1.20 Billion | CN¥1.28 Billion | CN¥79.05 Million | ▲ +74.1% |
| 2020 | CN¥691.09 Million | CN¥836.00 Million | CN¥144.91 Million | ▲ +15.7% |
| 2019 | CN¥597.07 Million | CN¥754.35 Million | CN¥157.28 Million | ▲ +19.0% |
| 2018 | CN¥501.71 Million | CN¥609.80 Million | CN¥108.09 Million | ▲ +15.0% |
| 2017 | CN¥436.41 Million | CN¥625.78 Million | CN¥189.38 Million | ▲ +20.3% |
| 2016 | CN¥362.67 Million | CN¥631.82 Million | CN¥269.14 Million | — |